Literature DB >> 1688609

Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria.

J P Tam1, P Clavijo, Y A Lu, V Nussenzweig, R Nussenzweig, F Zavala.   

Abstract

We show here an effective and novel approach to engineer peptide-based vaccines using a chemically defined system, known as multiple peptide antigen systems (MAPs), to protect an inbred mouse strain from infection against rodent malaria. 10 mono- and di-epitope MAP models containing different arrangements and stoichiometry of functional B and/or T helper cell epitopes from the circumsporozoite protein of Plasmodium berghei were used to immunize A/J mice. While these mice did not respond to the mono-epitope MAP bearing only the B or T epitope, very high titers of antibody and protective immunity against sporozoite challenge were elicited by di-epitope MAPs, particularly those with the B and T epitopes in tandem and present in equimolar amounts. These results, obtained in a well-defined rodent malaria model, indicate that MAPs may overcome some of the difficulties in the development of synthetic vaccines, not only for malaria but also for other infectious diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688609      PMCID: PMC2187660          DOI: 10.1084/jem.171.1.299

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

Review 1.  Rationale for the development of an engineered sporozoite malaria vaccine.

Authors:  V Nussenzweig; R S Nussenzweig
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

2.  Recombinant human gamma interferon inhibits simian malaria.

Authors:  R K Maheshwari; C W Czarniecki; G P Dutta; S K Puri; B N Dhawan; R M Friedman
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

3.  A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain.

Authors:  D N Posnett; H McGrath; J P Tam
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

4.  Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.

Authors:  J P Tam
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

5.  Plasmodium berghei: relationship between protective immunity and anti-sporozoite (CSP) antibody in mice.

Authors:  G L Spitalny; R S Nussenzweig
Journal:  Exp Parasitol       Date:  1973-02       Impact factor: 2.011

6.  Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria.

Authors:  F Zavala; J P Tam; M R Hollingdale; A H Cochrane; I Quakyi; R S Nussenzweig; V Nussenzweig
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

7.  Plasmodium berghei: cloning of the circumsporozoite protein gene.

Authors:  J L Weber; J E Egan; J A Lyon; R A Wirtz; Y Charoenvit; W L Maloy; W T Hockmeyer
Journal:  Exp Parasitol       Date:  1987-06       Impact factor: 2.011

8.  Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development.

Authors:  J E Egan; J L Weber; W R Ballou; M R Hollingdale; W R Majarian; D M Gordon; W L Maloy; S L Hoffman; R A Wirtz; I Schneider
Journal:  Science       Date:  1987-04-24       Impact factor: 47.728

9.  Circumsporozoite protein of Plasmodium berghei: gene cloning and identification of the immunodominant epitopes.

Authors:  D J Eichinger; D E Arnot; J P Tam; V Nussenzweig; V Enea
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

10.  Synthetic peptide vaccine confers protection against murine malaria.

Authors:  F Zavala; J P Tam; P J Barr; P J Romero; V Ley; R S Nussenzweig; V Nussenzweig
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  30 in total

1.  Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.

Authors:  M B Joshi; A A Gam; R A Boykins; S Kumar; J Sacci; S L Hoffman; H L Nakhasi; R T Kenney
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 2.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

3.  Immune responses in congenic mice to multiple antigen peptides based on defined epitopes from the malaria antigen Pf332.

Authors:  N Ahlborg; R Andersson; P Perlmann; K Berzins
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

4.  Immunogenicity of a contiguous T-B synthetic epitope of the A/PR/8/34 influenza virus.

Authors:  T D Brumeanu; S Casares; A Bot; S Bot; C A Bona
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria.

Authors:  D E Lanar; J A Tine; C de Taisne; M C Seguin; W I Cox; J P Winslow; L A Ware; E B Kauffman; D Gordon; W R Ballou; E Paoletti; J C Sadoff
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

6.  The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria.

Authors:  M Rodrigues; R S Nussenzweig; F Zavala
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

7.  Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytes.

Authors:  D Grillot; D Valmori; P H Lambert; G Corradin; G Del Giudice
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

8.  How well can a T-cell epitope replace its parent carrier protein? A dose-response study.

Authors:  James S Cavenaugh; Hsu-Kun Wang; Cory Hansen; Richard S Smith; James N Herron
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

9.  Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacy.

Authors:  Diego A Espinosa; Anjali Yadava; Evelina Angov; Paul L Maurizio; Christian F Ockenhouse; Fidel Zavala
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

10.  An improved protocol for coupling synthetic peptides to carrier proteins for antibody production using DMF to solubilize peptides.

Authors:  Syed Salman Lateef; Shalini Gupta; Lasanthi P Jayathilaka; Sangeeth Krishnanchettiar; Jin-Sheng Huang; Bao-Shiang Lee
Journal:  J Biomol Tech       Date:  2007-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.